Engineered virus-like particles for efficient in vivo delivery of therapeutic proteins
Samagya Banskota(Broad Institute), David R. Liu(Broad Institute), Elliot H. Choi(University of California, Irvine), Mark J. Osborn(University of Minnesota), Peyton B. Randolph(Broad Institute), Susie Suh(University of California, Irvine), Gregory A. Newby(Broad Institute), Kiran Musunuru(University of Pennsylvania), Krzysztof Palczewski(University of California, Irvine), Jessie R. Davis(Broad Institute), Xiao Wang(University of Pennsylvania), Aditya Raguram(Broad Institute), Sarah C. Nielsen(University of Minnesota), Samuel W. Du(University of California, Irvine)
Cited by 656
Related Papers
CRISPResso2 provides accurate and rapid genome editing sequence analysis
|Nature Biotechnology|2019|1.8k
Cationic lipid-mediated delivery of proteins enables efficient protein-based genome editing in vitro and in vivo
|Nature Biotechnology|2014|1.5k
Prime genome editing in rice and wheat
|Nature Biotechnology|2020|867
Engineered pegRNAs improve prime editing efficiency
|Nature Biotechnology|2021|747